Global Angina Market is Estimated to Reach a Value of USD 14,456.58 Million by 2027

Angina Market is estimated to grow at CAGR of 5.90% with an estimated value of USD 14,456.58 million by 2027 with factor such as the descending charging pressure owing to its product nature which will act as restraint and may hinder the growth of the market in the forecast period of 2020 to 2027.

  • On the other hand, some of the factors like increase in hypertension and diabetic inhabitants because of the bad lifestyle and increase in consumption of smoking and alcohols are providing favorable backgrounds for the market to grow in the above mentioned forecast period.

Angina Market Scenario

According to Data Bridge Market Research, the angina market in developing regions is witnessing a growth in terms of its adoption rate, due to growing occurrence of coronary heart diseases and expansion of biobetters and biosimilars. The increasing elderly population is also likely to enhance the growth of the market in the forecast period of 2020 to 2027.

Now the question is which are the regions that angina market players should target? Data Bridge Market Research has forecasted large growth in Asia-Pacific region due to existence of developing economies such as China and India along with rising healthcare sector. On the contrary, North America is seen to dominate the angina market due to the developing healthcare sector, increasing healthcare expenses and a huge patient populace.

For more analysis on the angina market, request for a briefing with our analysts

Angina Market Developments

  • In August 2018, Sun Pharmaceutical Industries has launched a Kapspargo Sprinkle (metoprolol succinate) extensive release capsules in the U.S. This capsule was specially launched for the treatment of patient’s affliction from angina pectoris, hypertension, and heart failure.

Angina Market Scope

Angina market on the basis of countries is segmented into the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

  • All country based analysis of the angina market is further analyzed based on maximum granularity into further segmentation. Based on drug class, the angina market is segmented into beta blockers, nitrates & calcium channel blockers, angiotensin-converting enzyme inhibitors and others. On the basis of types, the angina market is segmented into stable angina and unstable angina, variant (prinzmetal) angina and microvascular angina. Based on end-user, the angina market is segmented into hospitals, cardiology centers and others.
  • Angina is a major symptom of the coronary artery disease and is explained as tightness, clutching, and heaviness in the chest. It is a kind of chest pain which occur due to reduced flow of blood to the heart. Some of the common symptoms of angina are shortness of breath, fatigue, nausea, and sweating.

To know more about the study,

Key Pointers Covered in the Angina Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Sanofi
  • Gilead
  • AstraZeneca
  • Pfizer Inc
  • Amgen
  • GlaxoSmithKline plc
  • Novartis AG
  • Forest Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Abbott Laboratories Inc
  • Saneron CCEL Therapeutics, Inc
  • Vasomedical, Inc
  • Cryopraxis  
  • Neovasc Inc
  • Ark Therapeutics Group plc

Above are the key players covered in the report, to know about more and exhaustive list of angina companies’, contact us

Research Methodology of Global Angina Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Global Acute Coronary Syndrome Market – Industry Trends and Forecast to 2026

lobal Heart Pump Devices Market – Industry Trends and Forecast to 2027

North America Diabetic Assays Market – Industry Trends and Forecast to 2027

Global Hypertension Management Devices Market – Industry Trends and Forecast to 2027

Browse in Healthcare Category Related Reports@